Fourth Annual Novel Vaccines: Design & Development
Renaissance Providence Hotel
5 Avenue of the Arts
Providence, RI
Fourth Annual Novel Vaccines: Design & Development
 Cambridge Healthtech Institute

Schedule of Presentations:

Monday, August 17, 2009
07:30:00 Registration and Morning Coffee
08:20:00 Chairperson’s Opening Remarks William M. Egan
08:30:00 Plenary Keynote Presentation Vaccines: Challenges for the Future Norman Baylor
09:15:00 Plenary Featured Presentation Risk-Based Modelling for Vaccine Supply Chain Capacity Assessment Susan Behrens
10:00:00 Networking Coffee Break with Exhibit and Poster Viewing
10:05:00 INFLUENZA
11:00:00 Chairperson’s Remarks William M. Egan
11:05:00 Vaccine Industry’s Contribution to Global Pandemic Preparedness Norbert W. Hehme
11:35:00 Vaccines and Immunotherapeutics Against Influenza: Technologies, Needs, Demands, and Future Suryaprakash Sambhara
12:05:00 PATH’s Influenza Vaccine Program: Vaccine Development for People in Developing Countries Rick Bright
12:35:00 Lunch on Your Own (Lunch Presentation Opportunity Available)
13:50:00 CANCER
13:55:00 Chairperson’s Remarks Eid Haddad
14:00:00 Passive Vaccination Using Redirected, Genetically Engineered, Designer T-Cells for Immunotherapy Zelig Eshhar
14:30:00 Live Bacterial Vaccines: The Use of Bioengineered Listeria Monocytogenes in the Clinic John Rothman
15:00:00 Sponsored Presentation (Opportunity Available)
15:15:00 Networking Refreshment Break with Exhibit and Poster Viewing
15:55:00 HIV/AIDS
16:00:00 Structure-Based Rational Design of HIV Env Immunogens for Vaccine Development Indresh K. Srivastava
16:30:00 The HIV-1 gp120 C5 Region as a Candidate Therapeutic Vaccine to Prevent Disease Progression Angus Dalgleish
17:00:00 Strategies for Effective Gene-Based Vaccines: Results from Clinical and Pre-Clinical Studies Margaret A. Liu
Tuesday, August 18, 2009
07:20:00 Check-In
07:30:00 Morning Coffee (Breakfast Sponsored Presentation Opportunity Available)
08:25:00 Chairperson’s Remarks
08:30:00 Development of a Novel Baculovirus-Insect Cell System to Assess the Impact of Protein Glycosylation on Influenza Virus Subunit Vaccines Donald Jarvis
09:00:00 Chimigen Platform Technology: A Platform of the Future for Immunotherapeutic Vaccine Development Rajan George
09:30:00 ApoVax104 as a Novel Therapeutic Vaccine Haval Shirwan
10:00:00 Networking Coffee Break with Exhibit and Poster Viewing
10:45:00 Vaccines: WIIFM (or I): An Industry Perspective on Vaccine Investment Decision Making Frank Malinoski
11:15:00 Interactive Panel Discussion How to Fund Vaccine Research & Development in Today’s Economy
12:15:00 End of “Novel Vaccines: Design & Development” meeting
12:30:00 End Of Day Two
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.